The OC43 coronavirus is a human pathogen that usually causes only the common cold. One of its key enzymes, similar to other coronaviruses, is the 2'-O-RNA methyltransferase (MTase), which is essential for viral RNA stability and expression. Here, we report the crystal structure of the 2'-O-RNA MTase in a complex with the pan-methyltransferase inhibitor sinefungin solved at 2.2-Å resolution. The structure reveals an overall fold consistent with the fold observed in other coronaviral MTases. The major differences are in the conformation of the C terminus of the nsp16 subunit and an additional helix in the N terminus of the nsp10 subunits. The structural analysis also revealed very high conservation of the S-adenosyl methionine (SAM) binding pocket, suggesting that the SAM pocket is a suitable spot for the design of antivirals effective against all human coronaviruses. IMPORTANCE Some coronaviruses are dangerous pathogens, while some cause only common colds. The reasons are not understood, although the spike proteins probably play an important role. However, to understand the coronaviral biology in sufficient detail, we need to compare the key enzymes from different coronaviruses. We solved the crystal structure of 2'-O-RNA methyltransferase of the OC43 coronavirus, a virus that usually causes mild colds. The structure revealed some differences in the overall fold but also revealed that the SAM binding site is conserved, suggesting that development of antivirals against multiple coronaviruses is feasible.

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Paules CI, Marston HD, Fauci AS. 2020. Coronavirus infections—more than just the common cold. JAMA 323:707–708. 10.1001/jama.2020.0757. PubMed DOI

Lefkowitz EJ, Dempsey DM, Hendrickson RC, Orton RJ, Siddell SG, Smith DB. 2018. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV). Nucleic Acids Res 46:D708–D717. 10.1093/nar/gkx932. PubMed DOI PMC

Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. 2006. Nidovirales: evolving the largest RNA virus genome. Virus Res 117:17–37. 10.1016/j.virusres.2006.01.017. PubMed DOI PMC

Vijgen L, Keyaerts E, MoëS E, Thoelen I, Wollants E, Lemey P, Vandamme A-M, Van Ranst M. 2005. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol 79:1595–1604. 10.1128/JVI.79.3.1595-1604.2005. PubMed DOI PMC

Mulder J, Masurel N. 1958. Pre-epidemic antibody against 1957 strain of Asiatic influenza in serum of older people living in the Netherlands. Lancet 271:810–814. 10.1016/S0140-6736(58)91738-0. PubMed DOI

Desforges M, Le Coupanec A, Brison E, Meessen-Pinard M, Talbot PJ. 2014. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol 807:75–96. 10.1007/978-81-322-1777-0_6. PubMed DOI PMC

Arbour N, Day R, Newcombe J, Talbot PJ. 2000. Neuroinvasion by human respiratory coronaviruses. J Virol 74:8913–8921. 10.1128/JVI.74.19.8913-8921.2000. PubMed DOI PMC

Desforges M, Desjardins J, Zhang C, Talbot PJ. 2013. The acetyl-esterase activity of the hemagglutinin-esterase protein of human coronavirus OC43 strongly enhances the production of infectious virus. J Virol 87:3097–3107. 10.1128/JVI.02699-12. PubMed DOI PMC

Snijder EJ, Decroly E, Ziebuhr J. 2016. The nonstructural proteins directing coronavirus RNA synthesis and processing. Adv Virus Res 96:59–126. 10.1016/bs.aivir.2016.08.008. PubMed DOI PMC

V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. 2021. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 19:155–170. 10.1038/s41579-020-00468-6. PubMed DOI PMC

Bradrick SS. 2017. Causes and consequences of flavivirus RNA methylation. Front Microbiol 8:2374. 10.3389/fmicb.2017.02374. PubMed DOI PMC

Gonzales-van Horn SR, Sarnow P. 2017. Making the mark: the role of adenosine modifications in the life cycle of RNA viruses. Cell Host Microbe 21:661–669. 10.1016/j.chom.2017.05.008. PubMed DOI PMC

Cross ST, Michalski D, Miller MR, Wilusz J. 2019. RNA regulatory processes in RNA virus biology. Wiley Interdiscip Rev RNA 10:e1536. 10.1002/wrna.1536. PubMed DOI PMC

Decroly E, Canard B. 2017. Biochemical principles and inhibitors to interfere with viral capping pathways. Curr Opin Virol 24:87–96. 10.1016/j.coviro.2017.04.003. PubMed DOI PMC

Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M, Jr, Shi PY, Diamond MS. 2010. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452–456. 10.1038/nature09489. PubMed DOI PMC

Krafcikova P, Silhan J, Nencka R, Boura E. 2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Nat Commun 11:3717. 10.1038/s41467-020-17495-9. PubMed DOI PMC

Rosas-Lemus M, Minasov G, Shuvalova L, Inniss NL, Kiryukhina O, Brunzelle J, Satchell KJF. 2020. High-resolution structures of the SARS-CoV-2 2′-O-methyltransferase reveal strategies for structure-based inhibitor design. Sci Signal 13:eabe1202. 10.1126/scisignal.abe1202. PubMed DOI PMC

Viswanathan T, Arya S, Chan SH, Qi S, Dai N, Misra A, Park JG, Oladunni F, Kovalskyy D, Hromas RA, Martinez-Sobrido L, Gupta YK. 2020. Structural basis of RNA cap modification by SARS-CoV-2. Nat Commun 11:3718. 10.1038/s41467-020-17496-8. PubMed DOI PMC

Decroly E, Debarnot C, Ferron F, Bouvet M, Coutard B, Imbert I, Gluais L, Papageorgiou N, Sharff A, Bricogne G, Ortiz-Lombardia M, Lescar J, Canard B. 2011. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2′-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog 7:e1002059. 10.1371/journal.ppat.1002059. PubMed DOI PMC

Hamil RL, Hoehn MM. 1973. A9145, a new adenine-containing antifungal antibiotic. I. Discovery and isolation. J Antibiot 26:463–465. 10.7164/antibiotics.26.463. PubMed DOI

Weiss SR. 2020. Forty years with coronaviruses. J Exp Med 217:e20200537. 10.1084/jem.20200537. PubMed DOI PMC

Lai MMC, Patton CD, Stohlman SA. 1982. Further characterization of messenger-RNAs of mouse hepatitis-virus—presence of common 5'-end nucleotides. J Virol 41:557–565. 10.1128/JVI.41.2.557-565.1982. PubMed DOI PMC

Frana MF, Behnke JN, Sturman LS, Holmes KV. 1985. Proteolytic cleavage of the E2-glycoprotein of murine coronavirus—host-dependent differences in proteolytic cleavage and cell-fusion. J Virol 56:912–920. 10.1128/JVI.56.3.912-920.1985. PubMed DOI PMC

Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. 2003. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300:1763–1767. 10.1126/science.1085658. PubMed DOI

Jia Z, Yan L, Ren Z, Wu L, Wang J, Guo J, Zheng L, Ming Z, Zhang L, Lou Z, Rao Z. 2019. Delicate structural coordination of the severe acute respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis. Nucleic Acids Res 47:6538–6550. 10.1093/nar/gkz409. PubMed DOI PMC

Xiao Y, Ma Q, Restle T, Shang W, Svergun DI, Ponnusamy R, Sczakiel G, Hilgenfeld R. 2012. Nonstructural proteins 7 and 8 of feline coronavirus form a 2:1 heterotrimer that exhibits primer-independent RNA polymerase activity. J Virol 86:4444–4454. 10.1128/JVI.06635-11. PubMed DOI PMC

Dinesh DC, Chalupska D, Silhan J, Koutna E, Nencka R, Veverka V, Boura E. 2020. Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein. PLoS Pathog 16:e1009100. 10.1371/journal.ppat.1009100. PubMed DOI PMC

Hillen HS, Kokic G, Farnung L, Dienemann C, Tegunov D, Cramer P. 2020. Structure of replicating SARS-CoV-2 polymerase. Nature 584:154–156. 10.1038/s41586-020-2368-8. PubMed DOI

Konkolova E, Klima M, Nencka R, Boura E. 2020. Structural analysis of the putative SARS-CoV-2 primase complex. J Struct Biol 211:107548. 10.1016/j.jsb.2020.107548. PubMed DOI PMC

Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R. 2020. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science 368:409–412. 10.1126/science.abb3405. PubMed DOI PMC

Li WH, Moore MJ, Vasilieva N, Sui JH, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454. 10.1038/nature02145. PubMed DOI PMC

Shang J, Wan YS, Luo CM, Ye G, Geng QB, Auerbach A, Li F. 2020. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A 117:11727–11734. 10.1073/pnas.2003138117. PubMed DOI PMC

Raj VS, Mou HH, Smits SL, Dekkers DHW, Muller MA, Dijkman R, Muth D, Demmers JAA, Zaki A, Fouchier RAM, Thiel V, Drosten C, Rottier PJM, Osterhaus ADME, Bosch BJ, Haagmans BL. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251–254. 10.1038/nature12005. PubMed DOI PMC

Huang XC, Dong WJ, Milewska A, Golda A, Qi YH, Zhu QK, Marasco WA, Baric RS, Sims AC, Pyrc K, Li WH, Sui JH. 2015. Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme. J Virol 89:7202–7213. 10.1128/JVI.00854-15. PubMed DOI PMC

Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420–422. 10.1038/357420a0. PubMed DOI PMC

Wu K, Li W, Peng G, Li F. 2009. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc Natl Acad Sci U S A 106:19970–19974. 10.1073/pnas.0908837106. PubMed DOI PMC

Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S. 2005. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A 102:7988–7993. 10.1073/pnas.0409465102. PubMed DOI PMC

Tomáš O, Michal Š, Fengling L, Jindřich F, Kanchan D, Paknoosh P, Pavel H, Masoud V, Evzen B, Radim N. 2021. The structure-based design of SARS-CoV-2 Nsp14 methyltransferase ligands yields nanomolar inhibitors. ChemRxiv 10.26434/chemrxiv.14075408.v1. PubMed DOI

Devkota K, Schapira M, Perveen S, Yazdi AK, Li F, Chau I, Ghiabi P, Hajian T, Loppnau P, Bolotokova A, Satchell KJF, Wang K, Li D, Liu J, Smil D, Luo M, Jin J, Fish PV, Brown PJ, Vedadi M. 2021. Probing the SAM binding site of SARS-CoV-2 nsp14 in vitro using SAM competitive inhibitors guides developing selective bi-substrate inhibitors. bioRxiv 10.1101/2021.02.19.424337. PubMed DOI PMC

Yazdi AK, Li F, Devkota K, Perveen S, Ghiabi P, Hajian T, Bolotokova A, Vedadi M. 2021. A high-throughput radioactivity-based assay for screening SARS-CoV-2 nsp10-nsp16 complex. bioRxiv 10.1101/2021.02.03.429625. PubMed DOI PMC

Brecher M, Chen H, Li Z, Banavali NK, Jones SA, Zhang J, Kramer LD, Li HM. 2015. Identification and characterization of novel broad-spectrum inhibitors of the flavivirus methyltransferase. ACS Infect Dis 1:340–349. 10.1021/acsinfecdis.5b00070. PubMed DOI PMC

Lim SP, Sonntag LS, Noble C, Nilar SH, Ng RH, Zou G, Monaghan P, Chung KY, Dong HP, Liu BP, Bodenreider C, Lee G, Ding M, Chan WL, Wang G, Jian YL, Chao AT, Lescar J, Yin Z, Vedananda TR, Keller TH, Shi PY. 2011. Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem 286:6233–6240. 10.1074/jbc.M110.179184. PubMed DOI PMC

Coutard B, Barral K, Lichiere J, Selisko B, Martin B, Aouadi W, Lombardia MO, Debart F, Vasseur JJ, Guillemot JC, Canard B, Decroly E. 2017. Zika virus methyltransferase: structure and functions for drug design perspectives. J Virol 91:e02202-16. 10.1128/JVI.02202-16. PubMed DOI PMC

Hercik K, Brynda J, Nencka R, Boura E. 2017. Structural basis of Zika virus methyltransferase inhibition by sinefungin. Arch Virol 162:2091–2096. 10.1007/s00705-017-3345-x. PubMed DOI

Klima M, Chalupska D, Różycki B, Humpolickova J, Rezabkova L, Silhan J, Baumlova A, Dubankova A, Boura E. 2017. Kobuviral non-structural 3A proteins act as molecular harnesses to hijack the host ACBD3 protein. Structure 25:219–230. 10.1016/j.str.2016.11.021. PubMed DOI

Sebera J, Dubankova A, Sychrovsky V, Ruzek D, Boura E, Nencka R. 2018. The structural model of Zika virus RNA-dependent RNA polymerase in complex with RNA for rational design of novel nucleotide inhibitors. Sci Rep 8:11132. 10.1038/s41598-018-29459-7. PubMed DOI PMC

Kabsch W. 2010. XDS. Acta Crystallogr D Biol Crystallogr 66:125–132. 10.1107/S0907444909047337. PubMed DOI PMC

McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40:658–674. 10.1107/S0021889807021206. PubMed DOI PMC

Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213–221. 10.1107/S0907444909052925. PubMed DOI PMC

Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486–501. 10.1107/S0907444910007493. PubMed DOI PMC

Baranowski MR, Nowicka A, Rydzik AM, Warminski M, Kasprzyk R, Wojtczak BA, Wojcik J, Claridge TD, Kowalska J, Jemielity J. 2015. Synthesis of fluorophosphate nucleotide analogues and their characterization as tools for (1)(9)F NMR studies. J Org Chem 80:3982–3997. 10.1021/acs.joc.5b00337. PubMed DOI

Structure of SARS-CoV-2 MTase nsp14 with the inhibitor STM957 reveals inhibition mechanism that is shared with a poxviral MTase VP39

Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase

SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses

Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16

Coronaviral RNA-methyltransferases: function, structure and inhibition

Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase

Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit